Best Practices for Treating Parkinson’s Disease: A Focus on Symptoms and Considerations for Manage
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
2
Pharmacy, Claims Data Show High Resmetirom Persistence in MASH
3
FDA Approves First Dual-Targeted Therapy for Advanced HNSCC
4
Survodutide Meets CV Safety End Point in SYNCHRONIZE-CVOT
5